This is a demonstration of the clinical reports generated by RSD-RS. All data shown is fictional for illustration purposes.
Clinical Report
Rejection Sensitivity Dysphoria Rating Scale
SAMPLE-001 | Self-report | 25 February 2026
Response patterns are consistent and completion time is appropriate. No data quality concerns identified.
Quality Metrics
- Patient ID
- SAMPLE-001
- Instrument
- RSD-RS-55 (55-Item Assessment)
- Informant
- Self-report
- Timepoint
- Baseline
- Age Group
- Adult
- Recall Period
- Past 3 months
- Completed
- 25 February 2026
- Version
- v0.1 (Provisional)
Severe rejection sensitivity. Frequent and severe symptoms across many items requiring clinical attention.
Primary difficulties in emotional pain response and anticipatory worry about rejection.
Highest scoring domains: Trigger Sensitivity, Dysphoric Pain & Shame
Functional Impact domain scores meet threshold for clinically significant interference. The patient reports substantial difficulties in daily functioning, relationships, and participation due to rejection sensitivity.
| Domain | Score | % | Level |
|---|---|---|---|
A Trigger Sensitivity Heightened sensitivity to perceived rejection or criticism | 18/20 | 90% | Very High |
B Dysphoric Pain & Shame Intense emotional pain and shame during rejection | 17/20 | 85% | Very High |
C Anticipatory Hypervigilance Scanning for and anticipating rejection signals | 16/20 | 80% | Very High |
D Acute Reactivity Immediate behavioral/emotional responses during episodes | 15/20 | 75% | Very High |
E Recovery & Aftermath Prolonged recovery, rumination, reassurance-seeking | 17/20 | 85% | Very High |
F Functional Impact Impact on relationships, work, and daily functioning | 15/20 | 75% | Very High |
RSD-RS Pro (Self-report, Baseline) completed 25 February 2026.
Total score of 98/120 falls within the severe range. Profile analysis indicates an Emotional-Anticipatory pattern, characterised by primary difficulties in emotional pain response and anticipatory worry about rejection.
Functional Impact domain scores meet threshold for clinically significant interference in daily functioning, relationships, and participation.
Findings are dimensional and should be interpreted within the broader clinical context, including ADHD presentation, co-occurring conditions, and treatment history. This instrument is currently in validation phase; severity bands are provisional.
Recommended Monitoring Schedule
RSD-RS-10-M at 6-8 weeks to track early treatment response. RSD-RS Pro Follow-up at 6-12 months for comprehensive follow-up with intervention context.
Elevated Severity
Consider comprehensive assessment for co-occurring conditions including anxiety disorders, mood disorders, and trauma history. Explore impact on treatment engagement and adherence.
Contributing to Global Understanding
This assessment contributes anonymised data to the international RSD-RS validation initiative. As our dataset grows, we will publish normative data, establish clinical cut-offs, and validate the instrument across diverse populations. Thank you for being part of this scientific endeavour to better understand rejection sensitivity in ADHD.
Ready to Generate Reports Like This?
Join clinics worldwide using RSD-RS to measure and monitor rejection sensitivity in their ADHD patients.